Winthrop Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$907K Buy
1,845
+81
+5% +$44K 0.23% 69
2025
Q4
$1.02M Sell
1,764
-57
-3% -$32.2K 0.24% 68
2025
Q3
$883K Buy
1,821
+22
+1% +$10.2K 0.21% 74
2025
Q2
$730K Sell
1,799
-16
-0.9% -$6.69K 0.18% 80
2025
Q1
$903K Buy
1,815
+11
+0.6% +$5.96K 0.25% 73
2024
Q4
$936K Buy
1,804
+74
+4% +$40.7K 0.25% 75
2024
Q3
$1.07M Buy
+1,730
New +$1.02M 0.51% 36
2024
Q1
Sell
-1,717
Closed -$911K 283
2023
Q4
$911K Buy
+1,717
New +$831K 0.3% 74

Other funds holding TMO

Winthrop Capital Management's TMO Position: Q1 2026 in Review

Winthrop Capital Management increased its Thermo Fisher Scientific (TMO) stake by 4.6% in Q1 2026, buying an estimated $44K and bringing the position to 1,845 shares worth $907K. The position accounts for 0.23% of the portfolio, ranked #69.

Winthrop Capital Management first reported a position in TMO in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.07M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Winthrop Capital Management held 1,845 shares of Thermo Fisher Scientific worth $907K as of Q1 2026.
  • Winthrop Capital Management bought 81 Thermo Fisher Scientific shares in Q1 2026, an estimated $44K.
  • Thermo Fisher Scientific made up 0.23% of Winthrop Capital Management's portfolio in Q1 2026, its #69 holding.
  • Winthrop Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 8 quarters since.
  • Winthrop Capital Management's Thermo Fisher Scientific position peaked at $1.07M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.